MagicMed Industries

Private Company

MagicMed Industries is a private company with a focus on developing a molecular derivatives library and patent portfolio dubbed the Psybrary™.

In December 2020 the Company raised $8.1 million via an oversubscribed private placement, with common shares priced at $0.50.

MagicMed Industries intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products. MagicMed’s molecular derivatives library, the Psybrary™ is anticipated to be an essential building block from which industry can develop new patented products.

Private Company

If MagicMed completes a go-public, this page will be updated with stock information and financials.

In the meantime, you may enquire about financing opportunities via the button below.

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.